The DOI matches its Crossref record.
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life
Abstract
Nitric oxide (NO), which accounts for the biological properties of endothelium-derived relaxing factor, is generated by NO synthase (NOS). The vascular endothelium contains two types of NOS: one is constitutively expressed (cNOS), and the other is inducible. Endothelium-mediated vasorelaxation is impaired in atherosclerotic vessels. To determine whether tumor necrosis factor (TNF)-alpha, which is commonly found in atherosclerotic lesions, has an effect on NOS message, we measured cNOS mRNA levels in TNF-treated human umbilical vein endothelial cells (HUVECs) by RNA blot analysis with a cNOS cDNA probe. TNF-alpha markedly reduced cNOS mRNA levels in HUVECs in a dose- and time-dependent manner. In response to 3 ng/mL TNF-alpha, cNOS mRNA levels began to decrease at 4 hours and diminished to only 5% of control levels at 24 hours. As little as 0.1 ng/mL TNF-alpha reduced cNOS mRNA levels by 50%. This reduction in cNOS message in response to TNF-alpha depended on protein synthesis as it was blocked by cycloheximide. In nuclear runoff experiments, TNF-alpha did not change the rate of cNOS gene transcription. cNOS mRNA is very stable under basal conditions, with a half-life of 48 hours; however, treatment with TNF-alpha shortened this half-life to 3 hours. TNF-alpha thus appears to decrease cNOS mRNA levels by increasing the rate of mRNA degradation. TNF-induced reductions in cNOS mRNA levels may have an important effect on impaired endothelium-mediated vasorelaxation in atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“was shown to downregulate NOS3 expression and abundance [123, 131-134] by decreasing the stability of NOS3 mRNA [135, 136], effectively shortening its half-life [137].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [137]
Citations
Cited by
Sorted by citations
Items 501–600 of 775
Expression of endothelial angiotensin II receptor mRNA in pregnancy-induced hypertension
Takeda-Matsubara, Y. (2003) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.07.020 · Cited by 20
Exhaled nitric oxide as biomarker of acute lung injury: an unfulfilled promise?
Boshier, P. R., Hanna, G. B., & Marczin, N. (2013) · Journal of Breath Research · doi:10.1088/1752-7155/7/1/017118 · Cited by 20
“Further work identified that the negative effects of adherent monocytes on NO release was in fact a consequence of downregulation of steady-state levels of NOS III mediated by the monocyte-derived cytokines, tumour necrosis factoralpha (TNF-α) and interleukin (IL)-1 alpha [69, 70].”
BackgroundVascular endothelial function is improved by oral glycine treatment in aged rats
Gómez-Zamudio, J. H., García-Macedo, R., Lázaro‐Suárez, M. L., et al. (2015) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0393 · Cited by 20
“This activation reduced eNOS expression (Yoshizumi et al. 1993) and increased COX-2 expression (Singer et al.”
BackgroundIshibashi, Y., Shimada, T., Murakami, Y., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01582-0 · Cited by 20
Scott, J. A., & McCormack, D. G. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y98-136 · Cited by 20
Countervailing Influence of Tumor Necrosis Factor-α and Nitric Oxide in Endotoxemia
Jaimes, E. A., del Castillo, D., Rutherford, M. S., et al. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1261204 · Cited by 20
Žúbor, P., Dókuš, K., Zigo, I., et al. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000364865 · Cited by 19
Montiel‐Dávalos, A., Sánchez, G. J. S., Huerta-García, E., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188169 · Cited by 19
Mata‐Greenwood, E., Liao, W.-X., Wang, W., Zheng, J. J., & Chen, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.092791 · Cited by 18
Unpredictable Chronic Mild Stress Promotes Atherosclerosis in High Cholesterol–Fed Rabbits
Lu, X., Liu, Y., Zhang, L., Yang, R.-X., Liu, X., Yan, F., Wang, Y., Bai, W., Zhao, Y., & Jiang, F. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31825d0b71 · Cited by 19
“It has been demonstrated in cultured endothelial cells that TNF-> treatment downregulated eNOS expression by reducing eNOS mRNA stability (24).”
BackgroundHarmon, A. C., Ibrahim, T., Cornelius, D. C., et al. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.10.007 · Cited by 19
“Increased TNF-α activates endothelial cells, decreases nitric oxide synthase mRNA, and increases the production ET-1 by stimulating expression of PPET-1 mRNA (7-10,18).”
BackgroundHarry, G. J., Sills, R. C., Schlosser, M. J., et al. (2001) · Neurotoxicity Research · doi:10.1007/bf03033270 · Cited by 19
“TNFc~ is know to increase NOS activity in endothelial cells as well as significantly shorten the halflife of NOS sugesting a dynamic interaction between the two factors in various host-responses to injury (Yoshizumi et al., 1993).”
BackgroundKiss, H., Schneeberger, C., Tschugguel, W., Lass, H., Huber, J., Husslein, P. W., & Knöfler, M. (1998) · Placenta · doi:10.1016/s0143-4004(98)90021-2 · Cited by 19
Sardo, M. A., Castaldo, M., Cinquegrani, M., Bonaiuto, M., Fontana, L., Campo, S., Campo, G. M., Altavilla, D., & Saitta, A. (2004) · Angiology · doi:10.1177/000331970405500212 · Cited by 19
Endothelial Functions and Dysfunctions
Caterina, R. D., Massaro, M., & Libby, P. (2007) · doi:10.1002/9780470988473.ch1 · Cited by 19
Glial Cells as Nitric Oxide Sources and Targets
Murphy, S. P., Grzybicki, D. M., & Simmons, M. L. (1995) · Elsevier eBooks · doi:10.1016/b978-012721985-1/50011-3 · Cited by 19
Angolano, C., Kaczmarek, E., Essayagh, S., Daniel, S., Choi, L. Y., Tung, B., Sauvage, G., Lee, A., Kipper, F. C., Arvelo, M. B., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.651230 · Cited by 18
“The impact of A20 gain or loss on overall eNOS expression corresponded with increased or decreased mRNA levels of this enzyme, suggesting an effect on either eNOS mRNA stability/half-life or transcription (46).”
BackgroundRobinson, S. D., Dawson, P., Ludlam, C. A., Boon, N. A., & Newby, D. E. (2006) · Clinical Science · doi:10.1042/cs20050268 · Cited by 18
Araújo, A. V., Ferezin, C. Z., Pereira, A. C., et al. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.04.005 · Cited by 18
The periosteal microcirculation in health and disease: An update on clinical significance
Szabó, A., Janovszky, Á., Pócs, L., et al. (2016) · Microvascular Research · doi:10.1016/j.mvr.2016.11.005 · Cited by 18
Kalogeris, T. J., Baines, C. P., & Korthuis, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098459 · Cited by 18
Effect of C-reactive protein on Fcγ receptor II in cultured bovine endothelial cells
ESCRIBANO-BURGOS, M., López-Farré, A. J., GONZÁLEZ, M. D. M., Macaya, C., García‐Méndez, A., Mateos‐Cáceres, P. J., Alonso‐Orgaz, S., CARRASCO, C., RICO, L. A., & CUBERO, J. C. P. (2004) · Clinical Science · doi:10.1042/cs20040217 · Cited by 18
Guterbaum, T. J., Braunstein, T. H., Fossum, A., Holstein‐Rathlou, N., Torp-Pedersen, C. T., & Domínguez, H. (2013) · Journal of Vascular Research · doi:10.1159/000354225 · Cited by 17
Nitric oxide production in the ventilatory muscles in response to acute resistive loading
Vassilakopoulos, T., Govindaraju, K., Parthenis, D. G., Eidelman, D. H., Watanabe, Y., & Hussain, S. N. A. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00112.2006 · Cited by 17
“creases eNOS promoter activity as well as eNOS mRNA stability in a time- and dose-dependent manner (49).”
Are There Race-Dependent Endothelial Cell Responses to Exercise?
Brown, M. D., & Feairheller, D. L. (2012) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e318279cbbd · Cited by 17
“TNF-> decreases eNOS mRNA expression level by shortening its half-life (44).”
BackgroundRegulation of NO Synthesis in Endothelial Cells
Busse, R., & Fleming, I. (1998) · Kidney & Blood Pressure Research · doi:10.1159/000025872 · Cited by 17
Induction of myocardial nitric oxide synthase by Coxsackie B3 virus in mice
Robinson, Zhang, Bevan, Belder, D., Moncada, S., Martin, & Archard (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00505.x · Cited by 17
Effects of Hard Metal on Nitric Oxide Pathways and Airway Reactivity to Methacholine in Rat Lungs
Rengasamy, A., Kommineni, C., Jones, J. A., et al. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8668 · Cited by 17
Modulation of Endothelial Cell Nitric Oxide Synthase Expression
Harrison, D. G., Inoue, N., Ohara, Y., et al. (1996) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.60.815 · Cited by 17
Involvement of shedding induced by ADAM17 on the nitric oxide pathway in hypertension
da Silva, M. C., dos Santos, V. M., da Silva, M. V. B., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1032177 · Cited by 16
“Furthermore, TNF-α has also been shown to decrease eNOS mRNA levels in human endothelial cells (Yoshizumi et al., 1993).”
BackgroundPro-inflammatory cytokines as potential predictors for intradialytic hypotension
Yu, J., Chen, X., Li, Y., et al. (2021) · Renal Failure · doi:10.1080/0886022x.2021.1871921 · Cited by 16
“During dialysis, the activation of nitric oxide synthase (NOS) mediated by cytokines has been reported.”
BackgroundPOTENTIAL NEW THERAPIES FOR ALCOHOLIC LIVER DISEASE
Mullen, K. D., & Dasarathy, S. (1998) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70046-5 · Cited by 16
Um, J., Lee, J.-H., Joo, J., et al. (2005) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x05003156 · Cited by 16
“It also down-regulates endothelial nitric oxide synthase (Yoshizumi et al., 1993) and increases oxidative stress in endothelial cells (Toborek et al.”
BackgroundCalderone, A. (2003) · Heart Failure Reviews · doi:10.1023/a:1022147005110 · Cited by 16
The role of nitric oxide and protein kinase C in lipopolysaccharidemediated vascular hyporeactivity.
Karimi, G., Fatehi, Z., & Gholamnejad, Z. (2006) · PubMed · Cited by 16
Cell growth modulates nitric oxide synthase expression in fetal pulmonary artery endothelial cells
Whitney, J. A., German, Z., Sherman, T. S., Yuhanna, I. S., & Shaul, P. W. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.1.l131 · Cited by 16
“With the exception of tumor necrosis factor-a, which principally alters eNOS mRNA stability (28), studies of both humoral and physical modulators of eNOS indicate that levels of expression are primarily under transcriptional control (3, 9).”
BackgroundLi, W., Yang, W., Cao, H.-L., Wang, Y., Li, T.-T., Hu, H., & Wan, Q. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.303035 · Cited by 16
The Nitric Oxide-Endothelin-1 Connection
Alonso, D. C., & Radomski, M. W. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/1-4020-7960-5_13 · Cited by 15
Retinoic acid suppression of endothelial nitric oxide synthase in porcine oocyte
Hattori, M., Kato, Y., & Fujihara, N. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-099 · Cited by 15
Zhou, X. J., Laszik, Z. G., Ni, Z., Wang, X. Q., Brackett, D. J., Lerner, M. R., Silva, F. G., & Vaziri, N. D. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780113 · Cited by 14
“The decline in the eNOS protein is due to endothelial damage or injury, and/or to an increased production of cytokines, such as TNFa, which has been shown to destabilize eNOS mRNA and dramatically reduce eNOS activity in endothelial cells in vitro (Yoshizumi et al, 1993).”
BackgroundMiyano, H., Shishido, T., Kawada, T., Miyashita, H., Sato, T., Sugimachi, M., & Sunagawa, K. (1999) · Critical Care Medicine · doi:10.1097/00003246-199901000-00046 · Cited by 15
Hino, A., Tokuyama, Y., Weir, B., et al. (1996) · Neurosurgery · doi:10.1227/00006123-199609000-00026 · Cited by 15
Yi, B., Ozerova, M., Zhang, G., Yan, G., Huang, S., & Sun, J. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305750 · Cited by 14
Endothelial Cell Dysfunction and Oxidative Stress
Taylor, R. N., Davidge, S. T., & Roberts, J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374213-1.00009-4 · Cited by 16
Gillham, J. C., Myers, J., Baker, P. N., et al. (2008) · Hypertension in Pregnancy · doi:10.1080/10641950701825796 · Cited by 14
“These effects could be due to TNF- α reducing NO bioavailability (20) or interfering with gap junction expression and/or function contributing to EDHF-mediated relaxation.”
BackgroundNitric Oxide Administration Restores the Hepatic Artery Buffer Response During Porcine Endotoxemia
Tamandl, D., Jørgensen, P. F., Gundersen, Y., Fuegger, R., Sautner, T., Aasen, A. O., & Goetzinger, P. (2008) · Journal of Investigative Surgery · doi:10.1080/08941930802130131 · Cited by 14
“Other reports have shown that endotoxin and the consecutively released cytokine TNF-α both inhibit the synthesis of NO in vascular preparations [15, 16].”
BackgroundSuschek, C. V., Bonmann, E., Kleinert, H., Wenzel, M., Mahotka, C., Kolb, H., Förstermann, U., Gerharz, C., & Kolb-Bachofen, V. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703576 · Cited by 14
“Additionally, control cells were incubated with TNF-a plus IL-1b (1000 u ml71 each), cytokines which were shown to decrease endothelial ecNOS stability (Alonso et al., 1997; Yoshizumi et al., 1993).”
MethodGabazza, E. C., Hayashi, T., Ido, M., et al. (2002) · Clinical Science · doi:10.1042/cs1020167 · Cited by 14
Nitric oxide enhances PGI2production by human pulmonary artery smooth muscle cells
Wen, F., Watanabe, K., & Yoshida, M. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0168 · Cited by 14
Arriero, M., de la Pinta, J. C., Escribano, M., Celdrán, Á., Alameda, L. E. M., García-Cañete, J., Jiménez, A. M., Casado, S., Farré, J., & López-Farré, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000013699.74563.42 · Cited by 14
Coping with endothelial superoxide: potential complementarity of arginine and high-dose folate
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2002.11.006 · Cited by 14
Molecular Biology and Molecular Genetics of Nitric Oxide Synthase Genes
Nadaud, S., & Soubrier, F. (1996) · Clinical and Experimental Hypertension · doi:10.3109/10641969609081761 · Cited by 14
Cardiac Cachexia: Pathophysiology and Clinical Implications
Steinborn, W., & Anker, S. D. (2003) · Cited by 13
Poor Tooth Brushing Behavior Is Associated with High Risk of Cardiovascular Events
Matsui, S., Maruhashi, T., Kishimoto, S., Kajikawa, M., Yusoff, F. M., Nakashima, A., Taguchi, A., & Higashi, Y. (2021) · International Journal of Cardiology · doi:10.1016/j.ijcard.2021.12.056 · Cited by 15
Kowalski, T. W., Fraga, L. R., Tovo‐Rodrigues, L., et al. (2016) · Scientific Reports · doi:10.1038/srep23404 · Cited by 13
Regulation of Cardiac Function by Nitric Oxide
Balligand, J. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57077-3_10 · Cited by 13
Endothelial dysfunction in chronic heart failure: clinical implications and therapeutic options
Belardinelli, R. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00525-3 · Cited by 13
Garczorz, W., Francuz, T., Siemianowicz, K., Kosowska, A., Kłych, A., Aghdam, M. R. F., & Jagoda, K. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.08.007 · Cited by 12
“TNFa can inhibit eNOS gene expression and induce iNOS gene expression in human endothelial cells [9,10].”
Malnutrition, inflammation, atherosclerosis in hemodialysis patients.
Jeznach-Steinhagen, A. E., Słotwiński, R., & Szczygieł, B. (2007) · PubMed · Cited by 12
Expression of CD70 Modulates Nitric Oxide and Redox Status in Endothelial Cells
Pandey, A. K., Waldeck‐Weiermair, M., Wells, Q. S., Xiao, W., Yadav, S., Eroğlu, E., Michel, T. M., & Loscalzo, J. (2022) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.122.317866 · Cited by 12
TNF-a(-238G/A and -308G/A) gene polymorphisms may not contribute to the risk of ischemic stroke
Gu, L., Wu, G., Su, L., Yan, Y., Liang, B., Tan, J., Cai, H., Jiang, H., Wei, Q., Shen, T., et al. (2015) · International Journal of Neuroscience · doi:10.3109/00207454.2015.1010200 · Cited by 12
“TNF can also down-regulate endothelial nitric oxide synthase and play a significant role in stimulating oxidative stress in endothelial cells [24, 25].”
BackgroundQian, X., Mata‐Greenwood, E., Liao, W. X., et al. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.08.017 · Cited by 12
Cardiovascular Benefits of Habitual Exercise in Systemic Lupus Erythematosus: A Review
Barnes, J. N., & Tanaka, H. (2012) · The Physician and Sportsmedicine · doi:10.3810/psm.2012.09.1980 · Cited by 12
MacKenzie, A. R., Dunning, L., Ferrell, W. R., et al. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.04.011 · Cited by 12
15-Deoxy-Δ12,14-prostaglandin-J2 inhibits expression of eNOS in human endothelial cells
Józkowicz, A., Nigisch, A., Winter, B., Weigel, G., Huk, I., & Dulak, J. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.05.001 · Cited by 12
Ma, X. L., Gao, F., Yao, C., Chen, J., Lopez, B. L., Christopher, T. A., Disa, J., Gu, J.-L., Ohlstein, E. H., & Yue, T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38969-4 · Cited by 12
Estrogen-TNF interactions and vascular inflammation
Ferreri, N. R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00193.2007 · Cited by 11
“The implications of elevated TNF levels in the context of reduced levels of sex hormones also relate to impaired function of the vascular endothelium associated with a decrease in nitric oxide availability, a mechanism that may be coupled to increased release of superoxide as well as a decrease in endothelial nitric o…”
BackgroundThe Molecular Mechanisms of Offspring Effects from Obese Pregnancy
Dowling, D., & McAuliffe, F. M. (2013) · Obesity Facts · doi:10.1159/000350706 · Cited by 11
Decreased flow-mediated dilatation in patients with rheumatoid arthritis: a meta-analysis
Xu, S.-Z., Wang, P., Guan, S., et al. (2016) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134068 · Cited by 11
Impairment of endothelium-dependent relaxation in the arteries cultured with fetal bovine serum
Yamawaki, H., Sato, K., Hori, M., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00969-8 · Cited by 11
NO Synthesis and NOS Regulation
Förstermann, U., Li, H., Schwarz, P. M., & Kleinert, H. (2003) · Springer eBooks · doi:10.1007/0-306-48412-9_7 · Cited by 12
Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies
Jones, E. A. V. (2023) · Current Heart Failure Reports · doi:10.1007/s11897-023-00618-w · Cited by 11
“TNF-α increases the rate of eNOS mRNA degradation leading to reduced endothelial dependent relaxation [60].”
BackgroundNanoliposomal Nitroglycerin Exerts Potent Anti-Inflammatory Effects
Ardekani, S., Scott, H. A., Gupta, S., Eum, S., Yang, X. Q., Brunelle, A. R., Wilson, S. M., Mohideen, U., & Ghosh, K. (2015) · Scientific Reports · doi:10.1038/srep16258 · Cited by 10
The Role of Tumor Necrosis Factor in Cardiac Disease
Retter, A. S., & Frishman, W. H. (2001) · Heart Disease · doi:10.1097/00132580-200109000-00008 · Cited by 10
Tetrahydrobiopterin in the vascular system
Walter, R. B., Schaffner, A., & Schoedon, G. (2001) · Pteridines · doi:10.1515/pteridines.2001.12.3.93 · Cited by 10
Chmielewski, M. S., Heimbürger, O., Stenvinkel, P., & Lindholm, B. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00004-7 · Cited by 12
Oxidants and Endothelial Dysfunction
Lund, A. K. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00712-0 · Cited by 12
Aberle, S., Young, T. A., Medberry, P. S., Parkinson, J. F., Rubanyi, G. M., & Kauser, K. Z. (1997) · Nitric Oxide · doi:10.1006/niox.1997.0129 · Cited by 9
Cell and molecular biology of nitric oxide synthases.
Féron, O., & Michel, T. M. (2000) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1007/978-1-59259-002-5_2 · Cited by 9
“The TNF-α-induced decrease in the abundance of the eNOS mRNA in bovine aortic endothelial cells appears to be due to a decrease in eNOS mRNA stability (65); in contrast, transforming growth factor-β appears to increase the abundance of the eNOS transcript (66).”
BackgroundOxidative Stress, Vascular Dysfunction and Heart Failure
Bassenge, E., Fink, B., & Schwemmer, M. (1999) · Heart Failure Reviews · doi:10.1023/a:1009820324010 · Cited by 9
Beberashvili, I., Sinuani, I., Azar, A., et al. (2013) · International Urology and Nephrology · doi:10.1007/s11255-013-0436-9 · Cited by 8
Outzen, E. M., Zaki, M., Mehryar, R., Abdolalizadeh, B., Sajid, W., Boonen, H. C. M., Sams, A. G., & Sheykhzade, M. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12697 · Cited by 8
Xiao, J., Zhang, B., Su, Z., Liu, Y., Shelite, T. R., Chang, Q., Qiu, Y., Bei, J., Wang, P., Bukreyev, A. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101315 · Cited by 8
“TNFα can downregulate eNOS expression in ECs (67).”
Tsou, T., Yeh, S. C., Tsai, F., Chen, J.-W., & Chiang, H.-C. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.03.005 · Cited by 8
The Immunoregulatory Role of Cytokines in Congestive Heart Failure
Chen, O., Patel, J. A., Mohamed, E., Greene, M., Moskovits, N., & Shani, J. (2014) · Interdisciplinary Journal of Microinflammation · doi:10.4172/ijm.1000111 · Cited by 8
“Additionally, other pro-inflammatory cytokines like IL-1α, IL-2 and interferon-γ can induce TNFα production [15].”
BackgroundClark, J. R., Gregory, C. C., Matthews, I., et al. (2015) · Biomarkers · doi:10.3109/1354750x.2015.1118540 · Cited by 8
“TNF-a is an important mediator in atherosclerosis (Yoshizumi et al., 1993).”
BackgroundWalter, R. B., Blau, N., Kierat, L., Schaffner, A., & Schoedon, G. (1996) · Immunology Letters · doi:10.1016/s0165-2478(96)02638-7 · Cited by 8
Huonker, M., & Keul, J. (2001) · Zeitschrift für Kardiologie · doi:10.1007/s003920170080 · Cited by 8
“TNF-Alpha, IL-6) (50) die Stabilität des eNOS mRNA beeinträchtigt wird und dies zur Hemmung der stimulierten Freisetzung von NO beiträgt (4, 101).”
BackgroundRegulation of Endothelial NO Synthase mRNA Stability
Bloch, K. D. (1999) · Circulation Research · doi:10.1161/01.res.85.7.653 · Cited by 8
Cheung, Y. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-11851-7.00006-9 · Cited by 10
Etanercept Prevents Endothelial Dysfunction in Cafeteria Diet-Fed Rats
Răzvan-Valentin, S., Güler, S. A., Utkan, T., ŞAHİN, T. D., Gacar, G., Yazır, Y., Rençber, S. F., Lupușoru, M. O. D., Bălălău, C., Popescu, B., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042138 · Cited by 7
“Furthermore, TNF-α-mediated inflammation, which contributes to the development of many cardiovascular dysfunctions such as chronic heart failure, sepsis-associated cardiovascular disorders, myocardial ischemia-reperfusion injury, and atherosclerosis [9–11] reduces the release of NO and impairs NO-mediated vasorelaxati…”
BackgroundWebb, D., Rudholm-Feldreich, T., Gillberg, L., et al. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0812-5 · Cited by 7
“It is noteworthy that this effect, while seen consistently in acute (4 h) experiments, was not sustained in most cases after 5 days of YF476 treatment, suggestive of a desensitizing mechanism or isoform switching of NOS, which is known to occur (Yoshizumi et al. 1993; Vo et al. 2005), although the physiological meanin…”
Szabó, A., Hartmann, P., Varga, R., Jánvári, K., Lendvai, Z., Szalai, I., Gomez, I., Varga, G., Greksa, F., Németh, I., et al. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.11.004 · Cited by 7
The Effects of Exercise, Aspirin, and Celecoxib in an Atherogenic Environment
Grimm, H., Kretzschmar, J., Cook, M. D., et al. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001657 · Cited by 7
The role of α2‐adrenergic receptors in hypertensive preeclampsia: A hypothesis
Maaliki, D. S., Issa, K., Shehabi, T. S. A., EL‐Yazbi, A. F., & Eid, A. H. (2018) · Microcirculation · doi:10.1111/micc.12511 · Cited by 8
Cardiovascular Actions of Nitric Oxide
Rees, D. D. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46816-6_7 · Cited by 7
Endothelial Cell Dysfunction in Septic Shock
Vallet, B., & Leclerc, J. B. (1998) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-642-72038-3_12 · Cited by 7
Jeon, B. H., Chang, S. J., Kim, J. W., et al. (2000) · Endothelium · doi:10.3109/10623320009072211 · Cited by 7
Nitric Oxide and Endothelial Dysfunction
Dillon, G. A., & Vita, J. A. (2000) · doi:10.1007/978-1-59259-002-5_13 · Cited by 7
Differential Responses of Human Umbilical and Coronary Artery Endothelial Cells to Apoptosis
Staercke, C. D., Phillips, D. J., & Hooper, W. C. (2003) · Endothelium · doi:10.1080/10623320303369 · Cited by 7
Metadata
- Authors
- Yoshizumi, M., Perrella, M. A., Burnett, J. C., & Lee, M. E.
- Affiliations
- Harvard University (US)
- Venue
- Circulation Research
- Published
- 1993-07
- Volume
- 73
- Issue
- 1
- Pages
- 205-209
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2145570729
- Cited by
- 771
- References
- 0
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 13 · 2021: 15 · 2020: 16 · 2019: 12 · 2018: 16 · 2017: 14 · 2016: 11 · 2015: 17 · 2014: 35 · 2013: 19 · 2012: 18
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- TNF-α, endothelial nitric oxide synthase, constitutive nitric oxide synthase, mRNA stability, mRNA degradation, human umbilical vein endothelial cells, atherosclerosis, cycloheximide, gene transcription
- MeSH terms
- Amino Acid Oxidoreductases, Base Sequence, Endothelium, Vascular, Half-Life, Humans, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Necrosis Factor-alpha, Umbilical Veins, Down-Regulation, Polymerase Chain Reaction, Nitric Oxide Synthase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review